Medical devices behemoth Stryker agreed to buy Inari Medical for $4.9 billion. Inari stock catapulted Tuesday on the news.

Medical device maker Stryker said ... vascular diseases such as deep vein thrombosis and pulmonary embolism. “The acquisition of Inari expands Stryker's portfolio to provide life-saving ...

Stryker has entered a definitive agreement to acquire complete issued and outstanding shares of Inari Medical’s ... vascular conditions such as pulmonary embolism and deep vein thrombosis.

Inari Medical, Inc. NARI shares rallied ... such as deep vein thrombosis and pulmonary embolism. This company is expected to post quarterly loss of $0.04 per share in its upcoming report, which ...

Stryker acquires Inari Medical for $80/share ... for peripheral vascular diseases such as deep vein thrombosis and pulmonary embolism. Also Read: Morgan Stanley Maintains Positive MedTech Outlook ...

Charles R. Goulding and Preeti Sulibhavi examine how Stryker's acquisition of Inari Medical is set to transform vascular care ...

Stryker (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire all of the issued and outstanding shares of common stock of Inari Medical, Inc. (NASDAQ: ...

Portage, Michigan and Irvine, California, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire all of ...

(MENAFN- GlobeNewsWire - Nasdaq) Portage, Michigan and Irvine, California, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today a ...

Why the splash? Inari's game-changing clot-removal devices for deep vein thrombosis (DVT) and pulmonary embolism (PE) are a perfect fit for Stryker's neurovascular empire. This move doesn't just pad ...